Prof. Bernard T Golding
With over 500 publications in synthetic organic chemistry (including lipids), mechanistic enzymology and medicinal chemistry, he is the co-discoverer of a new anticancer drug recently approved by the FDA and EMA.
Honours & Awards
Over 500 Publications
Research publications: http://www.ncl.ac.uk/chemistry/staff/profile/bernardgolding.html
Co-winner of First Translational Research Prize (2010, Cancer Research UK)
Honorary DPhil (2005, University of Stockholm)